Home
Corporate
Operations
- R & D
- Project Portfolio
- Prioritized projects
  - Lipsovir
  - TMC435
  - MIV-701
  - HIV PI
  - HCV POL
  - KOL PI
  - Renin
  - BACE
  - Cathepsin K
  - Cathepsin S
- Polymerase inhibitor projects
  - Valomaciclovir
  - Alovudine
  - MIV-210
  - MIV-150
  - MIV-410
  - MIV-160
- Technologies
- Patents
IR & Media
Career and Contact
Search

MIV-150

Therapy Area
A NNRTI HIV as vaginal microbicide in combination with Carraguard® (PC815) to protect women against HIV infection.

Competitive Edge
Broad activity and excellent safety profile. No effective product on the market.

Licensee
Population Council

Last Modified: 05/09/2008